U-LABA/ICS Effects on Exercise Performance, Formoterol
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Symbicort
Related studies linked through entity extraction aliases.
Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.
- Status
- COMPLETED
- Phase
- PHASE3
Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients
- Status
- COMPLETED
- Phase
- PHASE3
Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis
- Status
- UNKNOWN
- Phase
- PHASE4
Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE3
Effects of Symbicort on the Ventilatory Kinematics
- Status
- TERMINATED
- Phase
- PHASE4
Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant
- Status
- TERMINATED
- Phase
- PHASE2
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
- Status
- COMPLETED
- Phase
- PHASE3
Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations
- Status
- COMPLETED
- Phase
- NA
Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler
- Status
- COMPLETED
- Phase
- N/A
Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma
- Status
- COMPLETED
- Phase
- N/A